Skip to main content

Table 3 Number of patients with total VTE according to underlying specific tumor subtypes

From: Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study

  Total VTE No. of patients Prevalence
Tumor type (n = 29) (n = 97) (%)
High-risk group for VTE
 Stomacha 5 18  
 Pancreasa 3 7  
 Ovarya 1 3  
 Lunga 2 2  
 Urinary tracta 1 2  
 CUPb 1 4  
 Sarcomab 2 3  
 Lymphomaa 0 1  
 Total 15 40 38c
Low-risk group for VTE
 Colon or rectum 6 26  
 Breast 5 22  
 Esophagus 3 6  
 Biliary tract 0 1  
 Liver 0 1  
 Urachus 0 1  
 Total 14 57 25
  1. VTE venous thromboembolism, CUP cancer of unknown primary
  2. aListed as a risk factor for VTE in National Comprehensive Cancer Network Guidelines 2016 [6]. bListed as a risk factor for VTE in Asian patients [18]. cOdds ratio was 1.84 vs. low-risk group for VTE (95% confidence interval, 0.8–4.4; P = 0.25).